Catalyst Pharmaceuticals (CPRX) EBIT Growth (1y) (2011 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 12.69% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 75.16% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -347.04% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 80.62% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 1.27% |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 8.65% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 1,386.07% |
| 10 | Catalyst Pharmaceuticals | 3.82 Bn | 3.07 Bn | 134.92 Mn | 15.57% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 15.57% |
| Dec 31, 2025 | -1.59% |
| Sep 30, 2025 | 30.17% |
| Jun 30, 2025 | 22.22% |
| Mar 31, 2025 | 133.60% |
| Dec 31, 2024 | 50.73% |
| Sep 30, 2024 | 236.90% |
| Jun 30, 2024 | 16.16% |
| Mar 31, 2024 | -23.82% |
| Dec 31, 2023 | 35.36% |
| Sep 30, 2023 | -248.15% |
| Jun 30, 2023 | 63.46% |
| Mar 31, 2023 | 105.05% |
| Dec 31, 2022 | 141.73% |
| Sep 30, 2022 | 79.25% |
| Jun 30, 2022 | 80.38% |
| Mar 31, 2022 | 77.19% |
| Dec 31, 2021 | 47.85% |
| Sep 30, 2021 | 19.65% |
| Jun 30, 2021 | 54.04% |
| Mar 31, 2021 | -8.40% |
| Dec 31, 2020 | 7.64% |
| Sep 30, 2020 | -15.46% |
| Jun 30, 2020 | -6.18% |
| Mar 31, 2020 | 1,183.25% |
| Dec 31, 2019 | 153.94% |
| Sep 30, 2019 | 269.20% |
| Jun 30, 2019 | 272.97% |
| Mar 31, 2019 | 83.35% |
| Dec 31, 2018 | -169.30% |
| Sep 30, 2018 | -90.00% |
| Jun 30, 2018 | -51.53% |
| Mar 31, 2018 | -26.79% |
| Dec 31, 2017 | -27.76% |
| Sep 30, 2017 | -10.03% |
| Jun 30, 2017 | 13.15% |
| Mar 31, 2017 | 24.97% |
| Dec 31, 2016 | 30.32% |
| Sep 30, 2016 | 21.99% |
| Jun 30, 2016 | 1.69% |
| Mar 31, 2016 | -45.33% |
| Dec 31, 2015 | -55.42% |
| Sep 30, 2015 | -22.11% |
| Jun 30, 2015 | -63.78% |
| Mar 31, 2015 | -22.33% |
| Dec 31, 2014 | -47.17% |
| Sep 30, 2014 | -26.60% |
| Jun 30, 2014 | -12.69% |
| Mar 31, 2014 | -105.72% |
| Dec 31, 2013 | -79.82% |
| Sep 30, 2013 | -152.84% |
| Jun 30, 2013 | -148.61% |
| Mar 31, 2013 | -24.97% |
| Dec 31, 2012 | 26.01% |
| Sep 30, 2012 | -13.50% |
| Jun 30, 2012 | 23.62% |
| Mar 31, 2012 | 10.17% |
| Dec 31, 2011 | -177.86% |
| Sep 30, 2011 | -24.50% |